Ocular manifestations of systemic lupus erythematosus
- PMID: 17681981
- DOI: 10.1093/rheumatology/kem173
Ocular manifestations of systemic lupus erythematosus
Abstract
Ocular manifestations of lupus are fairly common, may be the presenting feature of the disease and can be sight-threatening. Almost any part of the eye and visual pathway can be affected by inflammatory or thrombotic processes. Ocular pain and visual impairment require urgent assessment by an ophthalmologist. Infection should be excluded. Optic neuritis and ischaemic optic neuropathy may be difficult to distinguish. Scleritis and severe retinopathy require systemic immunosuppression but episcleritis, anterior uveitis and dry eyes can usually be managed with local eye drops. Vaso-occlusive disease, particularly in the presence of antiphospholipid antibodies, requires treatment with anticoagulation and proliferative retinopathy is treated with laser therapy. Hydroxychloroquine rarely causes ocular toxicity at doses under 6.5 mg/kg/day. When this has occurred, it has been associated with more than 5 years of drug exposure.
Similar articles
-
Systemic lupus erythematosus and ocular involvement: an overview.Clin Exp Med. 2018 May;18(2):135-149. doi: 10.1007/s10238-017-0479-9. Epub 2017 Dec 14. Clin Exp Med. 2018. PMID: 29243035 Review.
-
Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment.Clin Exp Ophthalmol. 2004 Feb;32(1):87-100. doi: 10.1046/j.1442-9071.2004.00766.x. Clin Exp Ophthalmol. 2004. PMID: 14746601 Review.
-
Severe vaso-occlusive retinopathy associated with systemic lupus erythematosus.Vojnosanit Pregl. 2016 Dec;73(12):1164-7. doi: 10.2298/VSP150605136R. Vojnosanit Pregl. 2016. PMID: 29341575
-
Hypopyon uveitis associated with systemic lupus erythematosus and antiphospholipid antibody syndrome.Graefes Arch Clin Exp Ophthalmol. 2005 Apr;243(4):386-8. doi: 10.1007/s00417-004-1022-8. Epub 2004 Oct 13. Graefes Arch Clin Exp Ophthalmol. 2005. PMID: 15864630
-
Optic neuropathy in systemic lupus erythematosus.Arch Ophthalmol. 1986 Apr;104(4):564-8. doi: 10.1001/archopht.1986.01050160120026. Arch Ophthalmol. 1986. PMID: 3954662
Cited by
-
Recurrent and Reversible, Bitemporal Field Defect from Presumed Chiasmitis in a Patient with Systemic Lupus Erythematosus.Neuroophthalmology. 2020 Jul 16;45(2):117-119. doi: 10.1080/01658107.2020.1766089. eCollection 2021. Neuroophthalmology. 2020. PMID: 34108783 Free PMC article.
-
Acute Unilateral Vision Loss Due to Optic Neuropathy in a Patient with Systemic Lupus Erythematosus.Am J Case Rep. 2019 Jan 23;20:97-100. doi: 10.12659/AJCR.912875. Am J Case Rep. 2019. PMID: 30670677 Free PMC article.
-
Uveitis in childhood-onset systemic lupus erythematosus patients: a multicenter survey.Clin Rheumatol. 2017 Mar;36(3):547-553. doi: 10.1007/s10067-016-3534-0. Epub 2017 Jan 9. Clin Rheumatol. 2017. PMID: 28070763
-
Concurrent Intracranial Hypertension and Bilateral Optic Neuritis in a Patient With Systemic Lupus Erythematosus: A Case Report.Clin Med Insights Case Rep. 2022 Sep 6;15:11795476221122649. doi: 10.1177/11795476221122649. eCollection 2022. Clin Med Insights Case Rep. 2022. PMID: 36091423 Free PMC article.
-
Crosstalk between Myopia and Inflammation: A Mini Review.Int J Med Sci. 2024 Jun 3;21(9):1589-1603. doi: 10.7150/ijms.94826. eCollection 2024. Int J Med Sci. 2024. PMID: 39006849 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical